Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/06/2026 | Q4 | $717M | -- | -- | $3.08 | -- |
| 11/07/2025 | Q3 | $702.4M | $733.8M | $3.43 | $2.93 | $0.51 |
| 08/22/2025 | Q2 | $635.2M | $759.2M | $4.41 | $2.23 | $2.18 |
| 05/09/2025 | Q1 | $622.4M | $664.2M | $2.98 | $1.97 | $1.01 |
| 02/07/2025 | Q4 | $517.4M | $599.9M | $2.26 | $2.14 | $0.12 |
| 11/08/2024 | Q3 | $553M | $550.3M | $2.12 | $1.63 | $0.48 |
| 08/23/2024 | Q2 | $538.2M | $507.5M | $1.72 | $1.74 | -$0.02 |
| 05/10/2024 | Q1 | $492.3M | $493M | $1.26 | $1.56 | -$0.30 |
| 02/09/2024 | Q4 | $489.1M | $465M | $1.36 | $1.64 | -$0.28 |
| 11/03/2023 | Q3 | -- | $463.1M | $1.45 | -- | -- |
| 08/25/2023 | Q2 | -- | $491.1M | $1.72 | -- | -- |
| 05/05/2023 | Q1 | -- | $457.8M | $1.63 | -- | -- |
| 02/03/2023 | Q4 | -- | $493.6M | $1.86 | -- | -- |
| 11/04/2022 | Q3 | -- | $498.1M | $1.54 | -- | -- |
| 08/26/2022 | Q2 | -- | $443.1M | $1.53 | -- | -- |
| 05/06/2022 | Q1 | -- | $358.1M | $0.82 | -- | -- |
| 02/04/2022 | Q4 | -- | $431.6M | $1.66 | -- | -- |
| 11/05/2021 | Q3 | -- | $458.9M | $2.11 | -- | -- |
| 08/27/2021 | Q2 | -- | $477.9M | $2.46 | -- | -- |
| 05/07/2021 | Q1 | -- | $467.2M | $2.32 | -- | -- |
| 02/05/2021 | Q4 | -- | $479.4M | $2.54 | -- | -- |
| 11/06/2020 | Q3 | -- | $473.5M | $2.46 | -- | -- |
| 08/21/2020 | Q2 | -- | $315.5M | $1.45 | -- | -- |
| 05/08/2020 | Q1 | -- | $337.4M | $1.60 | -- | -- |
| 02/07/2020 | Q4 | -- | $308.3M | $1.32 | -- | -- |
| 11/08/2019 | Q3 | -- | $323.3M | $1.43 | -- | -- |
| 08/09/2019 | Q2 | -- | $286.6M | $1.01 | -- | -- |
| 05/10/2019 | Q1 | -- | $284.9M | $1.25 | -- | -- |
| 02/08/2019 | Q4 | -- | $307.3M | $1.09 | -- | -- |
| 11/09/2018 | Q3 | -- | $282.9M | $1.16 | -- | -- |
| 08/24/2018 | Q2 | -- | $269.8M | $0.94 | -- | -- |
| 05/10/2018 | Q1 | -- | $250.4M | $1.32 | -- | -- |
| 02/08/2018 | Q4 | -- | $250.8M | -$0.66 | -- | -- |
| 11/09/2017 | Q3 | -- | $245.9M | $0.92 | -- | -- |
| 06/30/2017 | Q2 | -- | $228.6M | $0.74 | -- | -- |
| 03/31/2017 | Q1 | -- | $218.4M | $0.77 | -- | -- |
| 12/31/2016 | Q4 | -- | $213.5M | $0.72 | -- | -- |
| 09/30/2016 | Q3 | -- | $204.8M | $0.86 | -- | -- |
| 06/30/2016 | Q2 | -- | $185.7M | $0.69 | -- | -- |
| 03/31/2016 | Q1 | -- | $167.4M | $0.62 | -- | -- |
| 12/31/2015 | Q4 | -- | $161.9M | $0.57 | -- | -- |
Ubiquiti, Inc. reported $733.8M worth of top line sales in its most recent quarter.
Ubiquiti, Inc. announced earnings per share of $3.43 which represents a beat of analyst forecast a $2.93 per share.
Ubiquiti, Inc. reported $337.4M that represents $5.57 per share over the last quarter.
Ubiquiti, Inc.'s earnings are forecast to grow from $11.76 per share to $9.65 per share next year representing an increase of 6.52%.
Ubiquiti, Inc.'s next earnings date is February 6, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.